Animal Medicine Market Report 2026

Animal Medicine Market Overview

• Animal Medicine market size has reached to $53.76 billion in 2025 • Expected to grow to $73.34 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Rising Pet Ownership And Adoption Boosts The Animal Medicine Market • Market Trend: Growth Of Generic Veterinary Drugs Enhances Access To Affordable Long-Term Pet Treatments • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Animal Medicine Market?

Animal medicines refer to a collective term for drugs and therapies, including veterinary vaccines, veterinary antibiotics, and other veterinary pharmaceuticals, that are used to treat animal diseases to improve animals’ performance and health by identifying disease symptoms and drugs for the cure of illness. The main types of animal medicines are veterinary pharmaceuticals and feed additives, which are used for livestock and companion animals. Veterinary pharmaceuticals refer to animal medicine that is given to animals for treating diseases. Animal medicine is used by veterinary hospitals, pharmacies, drug stores, and veterinary clinics.

What Is The Animal Medicine Market Growth Forecast?

The animal medicine market size is expected to see strong growth in the next few years. It will grow to $73.34 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising demand for nutraceutical feed additives, technological innovations in veterinary drug formulations, increasing adoption of precision medicine for animals, growth in online veterinary medicine distribution, government initiatives to support animal health and disease prevention. Major trends in the forecast period include rising use of veterinary pharmaceuticals for companion and livestock animals, increasing adoption of feed additives to improve animal nutrition, growing preference for otc and prescription-based medicines, expansion of oral and parenteral administration routes, rising distribution through veterinary services and online channels.

Global Animal Medicine Market Segmentation

1) By Medicine: Veterinary Pharmaceuticals, Feed Additives 2) By Type Of Animal: Companion Animal, Livestock Animals 3) By Type Of Prescription: OTC, Prescription 4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations 5) By Distribution Channel: Veterinary Services, Online, Other Distribution Channels Subsegments: 1) By Veterinary Pharmaceuticals: Antimicrobials (Antibiotics, Antifungals), Anti-inflammatory Drugs, Vaccines, Anesthetics, Hormonal Treatments 2) By Feed Additives: Nutritional Supplements (Vitamins, Minerals), Probiotics And Prebiotics, Antioxidants, Growth Promoters, Antimicrobial Feed Additives

What Is The Driver Of The Animal Medicine Market?

Increasing rates of pet ownership and adoption are driving the growth of the animal medicine market going forward. Pet ownership is the state of being the primary person or household responsible for the care, well-being, and control of a domesticated animal. It involves a long-term, legal, and ethical commitment. Increasing pet ownership is rising due to the growing awareness of the emotional and health benefits of having pets, as people seek companionship, stress relief, and improved well-being through pet care. The animal medicine market supports increasing rates of pet ownership and adoption, as the growing number of pets drives demand for medicines that ensure animal health, disease prevention, and overall well-being. For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit association, ninety-four (94) million U.S. households own at least one pet, compared to eighty-two (82) million in 2023. Therefore, increasing rates of pet ownership and adoption are expected to propel the growth of the animal medicine industry.

Key Players In The Global Animal Medicine Market

Major companies operating in the animal medicine market are Zoetis, Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Virbac Group, Ceva Santé Animale, Phibro Animal Health Corporation, China Animal Husbandry Industry Co. Ltd, Vetoquinol S.A., Neogen Corporation, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Intervet Australia Pty Ltd, Jurox Pty Ltd, SeQuent Scientific Ltd, Guangdong Wens Dahuanong Biotechnology Co. Ltd, Shandong Lukang, Bayer Animal Health Cadila Pharmaceuticals Ltd., Koninklijke DSM n.v, Nutreco N.V., SaluVet GmbH, Interfeed, Biotex Plus Ltd., Cymedica, Vet Resolution, Vetruus Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, IDT Biologika, Vetiquinol S.A, UCBVET, Biowet Puławy, Pasteur Romania, Vector-Vita-LLC, NITA-FARM, Bioveta, Heska, Dechra Veterinary Products, IDEXX Laboratories, Agrodan CA, Agrovet Market S.A, Invesbio S.A, Sauvet, Vetanco, ALKE SAGLIK URUNLERI San. ve Tic. A.S., MISTAV Ilac ve Tavukculuk San.Tic.Ltd, Kahmavet, Lemavet, ASVET, Ekinos - Veterinary Products, Lanrex Pharmaceuticals Nig Ltd.

Global Animal Medicine Market Trends and Insights

Major companies operating in the animal medicine market are focusing on developing innovative products such as generic veterinary drugs for chronic conditions like urinary incontinence and heart failure, aiming to make essential long-term treatments more affordable and accessible for pets and their owners. A generic veterinary drug is a bioequivalent version of a previously approved brand-name medication that offers the same clinical efficacy and safety profile at a lower cost. For instance, in September 2025, ZyVet Animal Health Inc., a US-based provider of affordable generic pharmaceuticals for animals, launched the first FDA-approved generic phenylpropanolamine hydrochloride tablets for managing canine urinary incontinence, alongside a generic formulation of furosemide tablets for treating congestive heart failure and fluid retention in dogs and cats. These products are designed to deliver reliable clinical performance across multiple strengths to support precise dosing, offering veterinarians cost-effective options that improve long-term treatment adherence while expanding the availability of proven therapies previously limited by brand-name pricing. The launches reinforce ZyVet’s role in addressing unmet needs in the animal health generics segment and help bridge gaps in treatment access for everyday veterinary practice.

What Are Latest Mergers And Acquisitions In The Animal Medicine Market?

In July 2024, Merck Animal Health, a US-based company, acquired Elanco Animal Health Inc. The completion of this acquisition bolsters Merck Animal Health’s position in the aqua industry with a comprehensive approach to promote fish health, welfare, and sustainability in aquaculture, conservation, and fisheries. Merck aims to leverage this acquisition to provide a comprehensive range of solutions across both warm and cold-water species, including vaccines, anti-parasitic treatments, and nutritional supplements. Elanco Animal Health Incorporated, a US-based company.

Regional Outlook

North America was the largest region in the animal medicine market in 2025. Asia-Pacific was the second-largest region in the animal medicine market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Animal Medicine Market?

The animal medicine market consists of sales of procuring drugs to shield against external parasites like fleas, ticks, and heartworms (intestinal parasites). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.